Amgen is a large biopharmaceutical company based in California that develops medicines. Its filings show it lobbies Congress on health-related issues, especially funding for the Labor, Health and Human Services, and Education appropriations for fiscal year 2026. It has reported hiring a lobbying firm and disclosed about $180,000 in lobbying spending.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
STEPHANIE GADBOIS
The latest disclosures for this client.
CAPITOL 6 ADVISORS
Q2YCAPITOL 6 ADVISORS
Q1YCAPITOL 6 ADVISORS
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
CAPITOL 6 ADVISORS
KRISTIN CLARKSON
CAPITOL 6 ADVISORS
mrs KRISTIN RICHMOND CLARKSON
CAPITOL 6 ADVISORS
CAPITOL 6 ADVISORS
Q3CAPITOL 6 ADVISORS
Q2CAPITOL 6 ADVISORS
RR